100% target hit on $21621) Cup and handle
2) Ascending triangle
3) Price broke neckline
Entry on 12 Aug 2022
Currently sitting on almost 100% gain.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−3.00HKD
−397.09 MHKD
391.27 MHKD
157.33 M
About KEYMED BIOSCIENCES INC
Keymed Biosciences, Inc. is an investment holding company, which engages in the discovery and development of biological therapies in the autoimmune and oncology therapeutic areas. It operates through Hong Kong and China geographical segment. The company was founded on April 23, 2018 and is headquartered in Chengdu, China.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 2162 is 43.20 HKD — it has increased by 1.60% in the past 24 hours. Watch KEYMED BIOSCIENCES INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange KEYMED BIOSCIENCES INC stocks are traded under the ticker 2162.
2162 stock has fallen by −0.67% compared to the previous week, the month change is a 10.05% rise, over the last year KEYMED BIOSCIENCES INC has showed a −28.00% decrease.
We've gathered analysts' opinions on KEYMED BIOSCIENCES INC future price: according to them, 2162 price has a max estimate of 65.81 HKD and a min estimate of 49.58 HKD. Watch 2162 chart and read a more detailed KEYMED BIOSCIENCES INC stock forecast: see what analysts think of KEYMED BIOSCIENCES INC and suggest that you do with its stocks.
2162 reached its all-time high on Feb 2, 2023 with the price of 82.85 HKD, and its all-time low was 16.90 HKD and was reached on Mar 22, 2022. View more price dynamics on 2162 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
2162 stock is 4.11% volatile and has beta coefficient of 1.37. Track KEYMED BIOSCIENCES INC stock price on the chart and check out the list of the most volatile stocks — is KEYMED BIOSCIENCES INC there?
Today KEYMED BIOSCIENCES INC has the market capitalization of 12.03 B, it has decreased by −6.38% over the last week.
Yes, you can track KEYMED BIOSCIENCES INC financials in yearly and quarterly reports right on TradingView.
KEYMED BIOSCIENCES INC is going to release the next earnings report on Apr 1, 2025. Keep track of upcoming events with our Earnings Calendar.
2162 net income for the last half-year is −364.90 M HKD, while the previous report showed −438.97 M HKD of net income which accounts for 16.87% change. Track more KEYMED BIOSCIENCES INC financial stats to get the full picture.
No, 2162 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 5, 2024, the company has 897.00 employees. See our rating of the largest employees — is KEYMED BIOSCIENCES INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. KEYMED BIOSCIENCES INC EBITDA is −801.27 M HKD, and current EBITDA margin is −109.27%. See more stats in KEYMED BIOSCIENCES INC financial statements.
Like other stocks, 2162 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KEYMED BIOSCIENCES INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So KEYMED BIOSCIENCES INC technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating KEYMED BIOSCIENCES INC stock shows the buy signal. See more of KEYMED BIOSCIENCES INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.